INFLUENCE OF NANOSIZED CERIUM DIOXIDE ON THE VASCULAR BED OF THE LIVER UNDER THE CONDITIONS OF CHRONIC ALCOHOLIC HEPATITIS MODELING

Authors:

Abstract:

Chronic alcohol consumption changes the microcirculation of the liver and, depending on the duration and dose of ethanol, can have various negative consequences. Nanosized cerium dioxide can be an effective means of pathogenetic correction of ethanol-induced changes in the liver. The aim of the work was to study the effect of nanosized cerium dioxide on the morphometric indicators of the vascular bed of rat liver under the conditions of chronic alcoholic hepatitis modeling. The experiments were performed on 24 white, mature male Wistar rats, weighing 180–220 g. Animals modeled chronic alcoholic hepatitis according to Stepanov Yu.M. (2017) and nanosized cerium dioxide was administered intragastrically at a dose of 1 mg/kg in a volume of 2.9 ml/kg. The morphometric parameters of the inner diameter of the vessels of the liver lobe were determined; capillary lumen around the central vein and hepatic triad. Simulation of chronic alcoholic hepatitis leads to expansion of the central vein and narrowing of interlobular arteries and veins and lobular arterioles and venules. The introduction of nanodispersed cerium dioxide against the background of modeling chronic alcoholic hepatitis expands alcohol-narrowed lumens of interlobular arteries and veins and lobular arterioles and venules, without affecting the diameter of the central vein.

Keywords:

nanosized cerium dioxide vascular bed chronic alcoholic hepatitis liver rats

References:

1. Beregova TV, Neporada KS, Skrypnyk M, Falalyeyeva TM, Zholobak NM, Shcherbakov OB, et al. Efficacy of nanoceria for periodontal tissues alteration in glutamate-induced obese rats-multidisciplinary considerations for personalized dentistry and prevention. EPMA J. 2017; 8(1): 43-49. doi: 10.1007/s13167-017-0085-7.
2. Casals E, Zeng M, Parra-Robert M, Fernández-Varo G, Morales-Ruiz M, Jiménez W, et al. Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration. Small. 2020 May;16(20):e1907322. doi: 10.1002/smll.201907322.
3. Estevez AY, Pritchard S, Harper K, Aston JW, Lynch A, Lucky JJ, et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med. 2011; 51(6): 1155-63. doi: 10.1016/j.freeradbiomed.2011.06.006.
4. Ferreira CA, Ni D, Rosenkrans ZT, Cai W. Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Res. 2018; 11(10): 4955-4984. doi: 10.1007/s12274-018-2092-y.
5. Forouzanfar F, Pourbagher-Shahri AM, Darroudi M, Sadeghi M, Vafaee F, Moghadam OF, et al. Cerium Oxide Nanoparticles Ameliorate Oxidative Stress, Inflammation, and Pain Behavior in Neuropathic Rats. Curr Neurovasc Res. 2023;20(1):54-61. doi: 10.2174/1567202620666230125104604.
6. Guerra-Ojeda S, Marchio P, Rueda C, Suarez A, Garcia H, Victor VM, et al. Cerium dioxide nanoparticles modulate antioxidant defences and change vascular response in the human saphenous vein. Free Radic Biol Med. 2022 Nov 20;193(Pt 2):694-701. doi: 10.1016/j.freeradbiomed.2022.11.012.
7. Han H, Desert R, Das S, Song Z, Athavale D, Ge X, et al. Danger signals in liver injury and restoration of homeostasis. J Hepatol. 2020 Oct;73(4):933-951. doi: 10.1016/j.jhep.2020.04.033.
8. Mackowiak B, Fu Y, Maccioni L, Gao B. Alcohol-associated liver disease. J Clin Invest. 2024 Feb 1;134(3):e176345. doi: 10.1172/JCI176345.
9. Mykytenko AO, Akimov OYe, Yeroshenko GA, Neporada KS. Influence of transcription factor κb on remodeling of extracellular matrix of rat liver under conditions of chronic alcohol intoxication. World Med Biol. 2022; 2 (80): 214- 217. doi: 10.26724/2079-8334-2022-2-80-214-217.
10. Mykytenko AO, Akimov OYe, Yeroshenko GA, Shevchenko OM, Neporada KS. Changes in the microcirculatory bed of the liver during alcoholic hepatitis modeling. World Med Biol. 2023; 4 (86): 212- 216. doi: 10.26724/2079-8334-2023-4-86-212-216.
11. Sarnatskaya V, Shlapa Y, Yushko L, Shton I, Solopan S, Ostrovska G, et al. Biological activity of cerium dioxide nanoparticles. J Biomed Mater Res A. 2020 Aug 1;108(8):1703-1712. doi: 10.1002/jbm.a.36936.
12. Shen Y, Wang Z, Su L, Zheng L, Han Y, Jiao X, et al. Inhibition of angiotensin II type 1 receptor partially prevents acute elevation of pulmonary arterial pressure induced by endovascular ethanol injection. Hypertens Res. 2023; 46(4): 972-983. doi: 10.1038/s41440-022-01132-7.
13. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009; 89(4): 1269-339. doi: 10.1152/physrev.00027.2008.
14. Wu X, Fan X, Miyata T, Kim A, Cajigas-Du Ross CK, Ray S, et al. Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease. Annu Rev Pathol. 2023 Jan 24;18:411-438. doi: 10.1146/annurev-pathmechdis-031521-030435.
15. Zengin A, Erikçi A, Telli G, Gümüşel B, Kösemehmetoğlu K, Uçar G, et al. Anti-inflammatory effects of oral and intraperitoneal administration of cerium oxide nanoparticles on experimental hepatic ischemia-reperfusion injury. Turk J Surg. 2022; 38(3): 255-265. doi: 10.47717/turkjsurg.2022.5620.

Publication:

«World of Medicine and Biology» Vol. 20 No. 88 (2024) , с. 211-215
УДК 616.36-002-056.7:612.08

DOI:

https://doi.org/10.26724/2079-8334-2024-2-88-211-215